163 related articles for article (PubMed ID: 3157708)
41. Dioxin toxicity and chloracne in the Ukraine.
Sterling JB; Hanke CW
J Drugs Dermatol; 2005; 4(2):148-50. PubMed ID: 15776770
[TBL] [Abstract][Full Text] [Related]
42. Chloracne following environmental contamination by TCDD in Seveso, Italy.
Caramaschi F; del Corno G; Favaretti C; Giambelluca SE; Montesarchio E; Fara GM
Int J Epidemiol; 1981 Jun; 10(2):135-43. PubMed ID: 6457009
[TBL] [Abstract][Full Text] [Related]
43. Lipid abnormalities in workers exposed to dioxin.
Martin JV
Br J Ind Med; 1984 May; 41(2):254-6. PubMed ID: 6232943
[TBL] [Abstract][Full Text] [Related]
44. Changes in lymphocyte subsets in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Saberi Hosnijeh F; Lenters V; Boers D; Portengen L; Baeten E; Bueno-de-Mesquita HB; Heederik DJ; Bloem AC; Vermeulen R
Occup Environ Med; 2012 Nov; 69(11):781-6. PubMed ID: 22843439
[TBL] [Abstract][Full Text] [Related]
45. Dioxin-induced chloracne--reconstructing the cellular and molecular mechanisms of a classic environmental disease.
Panteleyev AA; Bickers DR
Exp Dermatol; 2006 Sep; 15(9):705-30. PubMed ID: 16881967
[TBL] [Abstract][Full Text] [Related]
46. Biochemical, neuropsychological, and neurological abnormalities following 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure.
Pelclová D; Fenclová Z; Dlasková Z; Urban P; Lukás E; Procházka B; Rappe C; Preiss J; Kocan A; Vejlupková J
Arch Environ Health; 2001; 56(6):493-500. PubMed ID: 11958548
[TBL] [Abstract][Full Text] [Related]
47. [Chloracne, porphyria cutanea tarda, and other poisonings due to the herbicides].
Jirásek L; Kalenský J; Kubec K; Pazderová J; Lukás E
Hautarzt; 1976 Jul; 27(7):328-33. PubMed ID: 134006
[TBL] [Abstract][Full Text] [Related]
48. Health risks of "dioxins": a review of environmental and toxicological considerations.
Dickson LC; Buzik SC
Vet Hum Toxicol; 1993 Feb; 35(1):68-77. PubMed ID: 8434461
[TBL] [Abstract][Full Text] [Related]
49. Dowling-Degos' disease mimicking chloracne.
Kershenovich J; Langenberg A; Odom RB; LeBoit PE
J Am Acad Dermatol; 1992 Aug; 27(2 Pt 2):345-8. PubMed ID: 1387658
[TBL] [Abstract][Full Text] [Related]
50. Exposure to polychlorinated dioxins and furans (PCDD/F) and mortality in a cohort of workers from a herbicide-producing plant in Hamburg, Federal Republic of Germany.
Flesch-Janys D; Berger J; Gurn P; Manz A; Nagel S; Waltsgott H; Dwyer JH
Am J Epidemiol; 1995 Dec; 142(11):1165-75. PubMed ID: 7485063
[TBL] [Abstract][Full Text] [Related]
51. A morbidity study of former pentachlorophenol-production workers.
Hryhorczuk DO; Wallace WH; Persky V; Furner S; Webster JR; Oleske D; Haselhorst B; Ellefson R; Zugerman C
Environ Health Perspect; 1998 Jul; 106(7):401-8. PubMed ID: 9637797
[TBL] [Abstract][Full Text] [Related]
52. Olestra increases faecal excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Geusau A; Tschachler E; Meixner M; Sandermann S; Päpke O; Wolf C; Valic E; Stingl G; McLachlan M
Lancet; 1999 Oct; 354(9186):1266-7. PubMed ID: 10520643
[TBL] [Abstract][Full Text] [Related]
53. Basis for a proposed reference dose (RfD) for dioxin of 1-10 pg/kg-day: a weight of evidence evaluation of the human and animal studies.
Greene JF; Hays S; Paustenbach D
J Toxicol Environ Health B Crit Rev; 2003; 6(2):115-59. PubMed ID: 12554432
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of diabetes mellitus, serum glucose, and thyroid function among United States workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Calvert GM; Sweeney MH; Deddens J; Wall DK
Occup Environ Med; 1999 Apr; 56(4):270-6. PubMed ID: 10450245
[TBL] [Abstract][Full Text] [Related]
55. AhR signalling and dioxin toxicity.
Sorg O
Toxicol Lett; 2014 Oct; 230(2):225-33. PubMed ID: 24239782
[TBL] [Abstract][Full Text] [Related]
56. Animal models of human response to dioxins.
Grassman JA; Masten SA; Walker NJ; Lucier GW
Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):761-75. PubMed ID: 9599728
[TBL] [Abstract][Full Text] [Related]
57. Lipid metabolism and neuropsychological follow-up study of workers exposed to 2,3,7,8- tetrachlordibenzo- p-dioxin.
Pelclová D; Fenclová Z; Preiss J; Procházka B; Spácil J; Dubská Z; Okrouhlík B; Lukás E; Urban P
Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S60-6. PubMed ID: 12397412
[TBL] [Abstract][Full Text] [Related]
58. Chloracne: a case series on cutaneous expression of CYP1A1 as diagnostic biomarker.
Chessa MA; La Placa M; Patrizi A; Virdi A; Misciali C; Fedrizzi G; Filippi F; Saurat JH; Sorg O; Fontao F; Kaya G; Neri I
Clin Exp Dermatol; 2021 Jul; 46(5):896-900. PubMed ID: 33638914
[TBL] [Abstract][Full Text] [Related]
59. Chloracne associated with employment in the production of pentachlorophenol.
O'Malley MA; Carpenter AV; Sweeney MH; Fingerhut MA; Marlow DA; Halperin WE; Mathias CG
Am J Ind Med; 1990; 17(4):411-21. PubMed ID: 2139304
[TBL] [Abstract][Full Text] [Related]
60. Dystonia and tremor following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Klawans HL
Mov Disord; 1987; 2(4):255-61. PubMed ID: 2849055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
